• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆置换与后续脉冲环磷酰胺同步治疗后重度系统性红斑狼疮的无治疗缓解

Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide.

作者信息

Euler H H, Schroeder J O, Harten P, Zeuner R A, Gutschmidt H J

机构信息

Christian Albrecht University, Kiel, Germany.

出版信息

Arthritis Rheum. 1994 Dec;37(12):1784-94. doi: 10.1002/art.1780371212.

DOI:10.1002/art.1780371212
PMID:7986225
Abstract

OBJECTIVE

To investigate the effect of an intensified treatment protocol synchronizing plasmapheresis with subsequent pulse cyclophosphamide for severe systemic lupus erythematosus (SLE).

METHODS

A protocol of plasmapheresis (3 x 60 ml/kg) and subsequent high-dose pulse cyclophosphamide (36 mg/kg) followed by 6 months of peroral immunosuppression was used to treat 14 patients with severe SLE.

RESULTS

Rapid improvement was achieved in all patients. Immunosuppressants, including corticosteroids, were withdrawn at month 6 in 12 patients. Eight patients continued without treatment for a mean observation period of 5.6 years (46-91 months).

CONCLUSION

The results demonstrate that treatment-free clinical remission can be achieved in some patients with severe SLE.

摘要

目的

探讨强化治疗方案(同步进行血浆置换及后续脉冲环磷酰胺治疗)对重症系统性红斑狼疮(SLE)的疗效。

方法

采用血浆置换方案(3×60 ml/kg)及后续大剂量脉冲环磷酰胺(36 mg/kg),随后进行6个月口服免疫抑制治疗,以治疗14例重症SLE患者。

结果

所有患者均迅速改善。12例患者在第6个月停用了包括皮质类固醇在内的免疫抑制剂。8例患者持续未接受治疗,平均观察期为5.6年(46 - 91个月)。

结论

结果表明,部分重症SLE患者可实现无需治疗的临床缓解。

相似文献

1
Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide.血浆置换与后续脉冲环磷酰胺同步治疗后重度系统性红斑狼疮的无治疗缓解
Arthritis Rheum. 1994 Dec;37(12):1784-94. doi: 10.1002/art.1780371212.
2
[Induction of remission in severe lupus erythematosus by intensified therapy].
Immun Infekt. 1989 Apr;17(2):51-3.
3
[Intensified therapy of severe lupus erythematosus].
Dtsch Med Wochenschr. 1991 Jul 12;116(28-29):1081-8. doi: 10.1055/s-2008-1063720.
4
Plasmapheresis and subsequent pulse cyclophosphamide in severe systemic lupus erythematosus. An interim report of the Lupus Plasmapheresis Study Group.
Ann Med Interne (Paris). 1994;145(5):296-302.
5
[Synchronizing therapy with plasmapheresis and cyclophosphamide in rapidly progressing systemic lupus erythematosis with kidney involvement].[血浆置换和环磷酰胺同步治疗伴肾脏受累的快速进展性系统性红斑狼疮]
Ter Arkh. 1996;68(5):27-30.
6
Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus.
Ann Intern Med. 1987 Sep;107(3):344-6. doi: 10.7326/0003-4819-107-2-344.
7
Plasmapheresis and subsequent pulse cyclophosphamide versus pulse cyclophosphamide alone in severe lupus: design of the LPSG trial. Lupus Plasmapheresis Study Group (LPSG).
J Clin Apher. 1991;6(1):40-7. doi: 10.1002/jca.2920060109.
8
[Use of plasmapheresis in therapy of systemic lupus erythematosus: a controlled study].[血浆置换在系统性红斑狼疮治疗中的应用:一项对照研究]
Acta Med Austriaca. 1988;15(5):155-8.
9
Treatment combining plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus.
Adv Exp Med Biol. 1989;260:203-13. doi: 10.1007/978-1-4684-5718-6_21.
10
A randomized trial of plasmapheresis and subsequent pulse cyclophosphamide in severe lupus: design of the LPSG trial.
Int J Artif Organs. 1991 Oct;14(10):639-46.

引用本文的文献

1
Risk factors of flare in patients with systemic lupus erythematosus after glucocorticoids withdrawal. A systematic review and meta-analysis.糖皮质激素撤药后系统性红斑狼疮患者病情复发的危险因素:系统评价和荟萃分析。
Lupus Sci Med. 2022 Jan;9(1). doi: 10.1136/lupus-2021-000603.
2
Application of Plasma Exchange in Steroid-Responsive Encephalopathy.血浆置换在类固醇反应性脑病中的应用。
Front Immunol. 2019 Feb 27;10:324. doi: 10.3389/fimmu.2019.00324. eCollection 2019.
3
Remission and withdrawal of therapy in lupus nephritis.狼疮性肾炎的缓解与治疗撤停
J Nephrol. 2016 Aug;29(4):559-65. doi: 10.1007/s40620-016-0313-6. Epub 2016 May 4.
4
Unilateral hemispheric primary angiitis of the central nervous system.中枢神经系统单侧半球原发性血管炎
J Neurol. 2011 Sep;258(9):1714-6. doi: 10.1007/s00415-011-5993-1. Epub 2011 Mar 18.
5
Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach.血浆置换在肾脏疾病中的益处与局限性:循证医学方法
J Artif Organs. 2011 Mar;14(1):9-22. doi: 10.1007/s10047-010-0529-5. Epub 2010 Dec 10.
6
Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome.静脉注射免疫球蛋白治疗变应性肉芽肿性血管炎的长期疗效
Ann Rheum Dis. 2004 Dec;63(12):1649-54. doi: 10.1136/ard.2003.015453.
7
Retrospective study of plasma exchange in children with systemic lupus erythematosus.
Pediatr Nephrol. 2004 Oct;19(10):1108-14. doi: 10.1007/s00467-004-1552-7. Epub 2004 Aug 5.
8
Treatment of severe proliferative lupus nephritis: the current state.重症增殖性狼疮性肾炎的治疗:现状
Ann Rheum Dis. 2003 Sep;62(9):799-804. doi: 10.1136/ard.62.9.799.
9
Treatment options for juvenile-onset systemic lupus erythematosus.青少年型系统性红斑狼疮的治疗选择。
Paediatr Drugs. 2002;4(4):241-56. doi: 10.2165/00128072-200204040-00004.
10
[Therapeutic plasma exchange 1996].[治疗性血浆置换 1996年]
Med Klin (Munich). 1997 Oct 15;92(10):615-20. doi: 10.1007/BF03044789.